12/26/2024

Janusmed kön och genus

Janusmed kön och genus – Fluzone High-Dose Quadrivalent

Janusmed kön och genus är ett kunskapsstöd som tillhandahåller information om köns- och genusaspekter på läkemedelsbehandling. Kunskapsstödet är avsedd främst för hälso- och sjukvårdspersonal. Texterna är generella och ska inte ses som behandlingsriktlinjer. Det är alltid behandlande läkare som ansvarar för patientens medicinering.

För att komma till startsidan för Janusmed kön och genus och för att göra sökningar klicka här.

Tillbaka till index
A A
A A

Vaccin mot influensa

Vaccin mot influensa

Klass : A

Visa all info

Skriv ut

Kontakta oss

  1. Klein SL, Morgan R. The impact of sex and gender on immunotherapy outcomes. Biol Sex Differ. 2020;11(1):24.

  2. Flucelvax Tetra (influenza virus). EPAR - Product information. European Medicines Agency (EMA) [updated 2023-07-08, cited 2023-12-04]

  3. Klein SL, Marriott I, Fish EN. Sex-based differences in immune function and responses to vaccination. Trans R Soc Trop Med Hyg. 2015;109(1):9-15.

  4. Denly L. The effect of sex on responses to influenza vaccines. Hum Vaccin Immunother. 2021;17(5):1396-1402.

  5. Engler RJ, Nelson MR, Klote MM, VanRaden MJ, Huang CY, Cox NJ et al. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Arch Intern Med. 2008;168(22):2405-14.

  6. Giurgea LT, Cervantes-Medina A, Walters KA, Scherler K, Han A, Czajkowski LM et al. Sex Differences in Influenza: The Challenge Study Experience. J Infect Dis. 2022;225(4):715-722.

  7. Sánchez-de Prada L, Ortiz de Lejarazu-Leonardo R, Castrodeza-Sanz J, Tamayo-Gómez E, Eiros-Bouza JM, Sanz-Muñoz I. Do Vaccines Need a Gender Perspective? Influenza Says Yes!. Front Immunol. 2021;12:715688.

  8. Kuo H, Shapiro JR, Dhakal S, Morgan R, Fink AL, Liu H et al. Sex-specific effects of age and body mass index on antibody responses to seasonal influenza vaccines in healthcare workers. Vaccine. 2022;40(11):1634-1642.

  9. Cook IF. Sex differences in injection site reactions with human vaccines. Hum Vaccin. 2009;5(7):441-9.

  10. Kiely M, Tadount F, Lo E, Sadarangani M, Wei SQ, Rafferty E et al. Sex differences in adverse events following seasonal influenza vaccines: a meta-analysis of randomised controlled trials. J Epidemiol Community Health. 2023;77(12):791-801.

  11. Slingerland P, van Hunsel FPAM, Lieber T, van Balveren L, Duijster JW. The Effect of Sex on the Incidence, Latency, Duration and Perceived Burden of Adverse Events Following Seasonal Influenza Vaccination in the Netherlands. Drug Saf. 2023;46(12):1323-1334.

  12. Klein SL, Jedlicka A, Pekosz A. The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis. 2010;10(5):338-49.

  13. Schmid P, Rauber D, Betsch C, Lidolt G, Denker ML. Barriers of Influenza Vaccination Intention and Behavior - A Systematic Review of Influenza Vaccine Hesitancy, 2005 - 2016. PLoS One. 2017;12(1):e0170550.

  14. Marti M, de Cola M, MacDonald NE, Dumolard L, Duclos P. Assessments of global drivers of vaccine hesitancy in 2014-Looking beyond safety concerns. PLoS One. 2017;12(3):e0172310.

  15. Tadount F, Doyon-Plourde P, Rafferty E, MacDonald S, Sadarangani M, Quach C. Is there a difference in the immune response, efficacy, effectiveness and safety of seasonal influenza vaccine in males and females? - A systematic review. Vaccine. 2020;38(3):444-459.

  16. Klein SL, Pekosz A. Sex-based biology and the rational design of influenza vaccination strategies. J Infect Dis. 2014;:.

  17. Yen CC, Wei KC, Wang WH, Huang YT, Chang YC. Risk of Guillain-Barré Syndrome Among Older Adults Receiving Influenza Vaccine in Taiwan. JAMA Netw Open. 2022;5(9):e2232571.

  18. Levison LS, Thomsen RW, Andersen H. Guillain-Barré syndrome following influenza vaccination: A 15-year nationwide population-based case-control study. Eur J Neurol. 2022;29(11):3389-3394.

  19. Fujimori M, Hasegawa S, Sasaoka S, Iguchi K, Nakamura M. A study of the association between seasonal influenza vaccines and the increased risk of Guillain-Barré syndrome using Vaccine Adverse Event Reporting System, 2018-2019. Pharmazie. 2021;76(9):437-443.

  20. de Abajo FJ, Rodríguez-Martín S, Barreira D, Rodríguez-Miguel A, Fernández-Antón E, Gil M et al. Influenza vaccine and risk of acute myocardial infarction in a population-based case-control study. Heart. 2022;108(13):1039-1045.

  21. Wang WH, Wei KC, Huang YT, Huang KH, Tsai TH, Chang YC. The Incidence of Myocarditis Following an Influenza Vaccination: A Population-Based Observational Study. Drugs Aging. 2023;40(2):145-151.

  1. Klein SL, Morgan R. The impact of sex and gender on immunotherapy outcomes. Biol Sex Differ. 2020;11(1):24.
  2. Flucelvax Tetra (influenza virus). EPAR - Product information. European Medicines Agency (EMA) [updated 2023-07-08, cited 2023-12-04]
  3. Klein SL, Marriott I, Fish EN. Sex-based differences in immune function and responses to vaccination. Trans R Soc Trop Med Hyg. 2015;109(1):9-15.
  4. Denly L. The effect of sex on responses to influenza vaccines. Hum Vaccin Immunother. 2021;17(5):1396-1402.
  5. Engler RJ, Nelson MR, Klote MM, VanRaden MJ, Huang CY, Cox NJ et al. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Arch Intern Med. 2008;168(22):2405-14.
  6. Giurgea LT, Cervantes-Medina A, Walters KA, Scherler K, Han A, Czajkowski LM et al. Sex Differences in Influenza: The Challenge Study Experience. J Infect Dis. 2022;225(4):715-722.
  7. Sánchez-de Prada L, Ortiz de Lejarazu-Leonardo R, Castrodeza-Sanz J, Tamayo-Gómez E, Eiros-Bouza JM, Sanz-Muñoz I. Do Vaccines Need a Gender Perspective? Influenza Says Yes!. Front Immunol. 2021;12:715688.
  8. Kuo H, Shapiro JR, Dhakal S, Morgan R, Fink AL, Liu H et al. Sex-specific effects of age and body mass index on antibody responses to seasonal influenza vaccines in healthcare workers. Vaccine. 2022;40(11):1634-1642.
  9. Cook IF. Sex differences in injection site reactions with human vaccines. Hum Vaccin. 2009;5(7):441-9.
  10. Kiely M, Tadount F, Lo E, Sadarangani M, Wei SQ, Rafferty E et al. Sex differences in adverse events following seasonal influenza vaccines: a meta-analysis of randomised controlled trials. J Epidemiol Community Health. 2023;77(12):791-801.
  11. Slingerland P, van Hunsel FPAM, Lieber T, van Balveren L, Duijster JW. The Effect of Sex on the Incidence, Latency, Duration and Perceived Burden of Adverse Events Following Seasonal Influenza Vaccination in the Netherlands. Drug Saf. 2023;46(12):1323-1334.
  12. Klein SL, Jedlicka A, Pekosz A. The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis. 2010;10(5):338-49.
  13. Schmid P, Rauber D, Betsch C, Lidolt G, Denker ML. Barriers of Influenza Vaccination Intention and Behavior - A Systematic Review of Influenza Vaccine Hesitancy, 2005 - 2016. PLoS One. 2017;12(1):e0170550.
  14. Marti M, de Cola M, MacDonald NE, Dumolard L, Duclos P. Assessments of global drivers of vaccine hesitancy in 2014-Looking beyond safety concerns. PLoS One. 2017;12(3):e0172310.
  15. Tadount F, Doyon-Plourde P, Rafferty E, MacDonald S, Sadarangani M, Quach C. Is there a difference in the immune response, efficacy, effectiveness and safety of seasonal influenza vaccine in males and females? - A systematic review. Vaccine. 2020;38(3):444-459.
  16. Klein SL, Pekosz A. Sex-based biology and the rational design of influenza vaccination strategies. J Infect Dis. 2014;:.
  17. Yen CC, Wei KC, Wang WH, Huang YT, Chang YC. Risk of Guillain-Barré Syndrome Among Older Adults Receiving Influenza Vaccine in Taiwan. JAMA Netw Open. 2022;5(9):e2232571.
  18. Levison LS, Thomsen RW, Andersen H. Guillain-Barré syndrome following influenza vaccination: A 15-year nationwide population-based case-control study. Eur J Neurol. 2022;29(11):3389-3394.
  19. Fujimori M, Hasegawa S, Sasaoka S, Iguchi K, Nakamura M. A study of the association between seasonal influenza vaccines and the increased risk of Guillain-Barré syndrome using Vaccine Adverse Event Reporting System, 2018-2019. Pharmazie. 2021;76(9):437-443.
  20. de Abajo FJ, Rodríguez-Martín S, Barreira D, Rodríguez-Miguel A, Fernández-Antón E, Gil M et al. Influenza vaccine and risk of acute myocardial infarction in a population-based case-control study. Heart. 2022;108(13):1039-1045.
  21. Wang WH, Wei KC, Huang YT, Huang KH, Tsai TH, Chang YC. The Incidence of Myocarditis Following an Influenza Vaccination: A Population-Based Observational Study. Drugs Aging. 2023;40(2):145-151.